Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Apomorphine (oromucosal use)

EU orphan designation number: EU/3/01/072
Active ingredient: Apomorphine (oromucosal use)
Indication: Treatment of off-periods in Parkinson's disease not responding to other oral treatment
Sponsor: Orion Corporation
Orionintie 1, FI-02200 Espoo, Suomi

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/12/2001 Orphan designation EMEA/OD/027/01 (2001)4024 of 05/12/2001
25/02/2005 Removal of orphan designation from Community Register